Evidence map›Paper›PMID 30932349›Full record

ArticleJournal of cellular and molecular medicine2019

IRF3 and IRF7 mediate neovascularization via inflammatory cytokines.

Karin H Simons, Margreet R de Vries, Rob C M de Jong, Hendrika A B Peters, J Wouter Jukema, Paul H A Quax

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Interferon regulatory factors orchestrate CD8International journal of molecular medicine · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Journal of thoracic disease · 2023
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. IRF3 and IRF7 mediate neovascularization via inflammatory cytokines.Journal of cellular and molecular medicine · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Karin H SimonsDepartment of Surgery, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0002-1604-8151
Margreet R de VriesDepartment of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
Rob C M de JongDepartment of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
Hendrika A B PetersDepartment of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
J Wouter JukemaEinthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Paul H A QuaxDepartment of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
Leiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo elucidate the role of interferon regulatory factor (IRF)3 and IRF7 in neovascularization.

methodsUnilateral hind limb ischaemia was induced in Irf3

resultsPost-ischaemic blood flow recovery was decreased in Irf3

conclusionDeficiency of IRF3 and IRF7 results in impaired post-ischaemic blood flow recovery caused by attenuated angiogenesis and arteriogenesis linked to a lack of inflammatory components in ischaemic tissue. Therefore, IRF3 and IRF7 are essential regulators of neovascularization.

Indexed as

AnimalsChemokine CCL2Collateral CirculationHindlimbInflammationInterferon Regulatory Factor-3Interferon Regulatory Factor-7Interleukin-6IschemiaMacrophagesMiceMice, Inbred C57BLMice, KnockoutMuscle, SkeletalNeovascularization, PathologicTumor Necrosis Factor-alphaCcl2 protein, mouseChemokine CCL2Interferon Regulatory Factor-3Interferon Regulatory Factor-7Interleukin-6interleukin-6, mouseIrf3 protein, mouseIrf7 protein, mouseKdr protein, mouseTnf protein, mouseTumor Necrosis Factor-alphaVascular Endothelial Growth Factor Receptor-2angiogenesisarteriogenesisinflammationinterferon regulatory factorneovascularization

Identifiers

PMID30932349
PMCPMC6533520
OpenAlexW2932242356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.